東方電氣(01072.HK)獲主要股東注入氫燃料電池業務設備和專利
東方電氣(01072.HK)公布,附屬公司東方氫能與公司之主要股東東方電氣集團訂立資產交易合同。據此,東方電氣集團同意向東方氫能轉讓與氫燃料電池業務相關的設備和無形資產,包括機器設備41台、電子設備1台以及軟件和專利等無形資產51項。轉讓價款為4,728.6萬元人民幣,從公司內部資源撥付。
公司指,於合同生效前,東方電氣集團仍持有部份氫能及燃料電池相關資產,東方氫能主要通過授權的方式使用。因此,購買相關資產有助於理清公司與主要股東資產關係。另外,目前氫能行業競爭日趨激烈,針對發展初期的公司,購買相關資產能幫助快速提升公司的綜合實力和資產規模,有利於後期市場開拓工作,提升市場地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.